Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Hospital Morales Meseguer
Murcia, EspañaPublications in collaboration with researchers from Hospital Morales Meseguer (130)
2024
-
Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842
-
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved
Thrombosis and Haemostasis
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
American Heart Journal, Vol. 258, pp. 1-16
-
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review
Science of the Total Environment, Vol. 880
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
-
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomedicine and Pharmacotherapy, Vol. 158
-
Reducing bleeding risk in patients on oral anticoagulation therapy
Expert Review of Cardiovascular Therapy, Vol. 21, Núm. 12, pp. 923-936
-
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases
Thrombosis and Haemostasis, Vol. 124, Núm. 4, pp. 320-323
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323
2022
-
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Thrombosis and Haemostasis, Vol. 122, Núm. 10, pp. 1625-1652
-
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 11, pp. 1844-1871
-
Current trends on antithrombotic therapy
REC: CardioClinics
-
Diagnostic and therapeutic potential of miRNAs in cardiovascular disease: a clinical reality?
Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 705-706
-
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
Frontiers in Cardiovascular Medicine
-
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence
British Journal of Clinical Pharmacology, Vol. 88, Núm. 1, pp. 282-289
-
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients
European Journal of Internal Medicine
-
Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
Journal of Personalized Medicine, Vol. 12, Núm. 3